“We will ensure sustainable growth momentum in the K-bio industry by spreading an organic collaboration model together with proactive and bold investments in future technologies.” ▲ Jon Lim, CEO of Samsung BioLogics, hosted a domestic bio conference held at Chosun Palace Seoul Gangnam Hotel on the 15th Giving a welcome speech at a seminar for the growth of joint industries. Provided by Samsung BioLogics
Jon Lim, CEO of Samsung BioLogics, presented Samsung BioLogics’ current business status and future technology investment plans under the title ‘Together, the future of K-Bio’ at a seminar for the mutual growth of the domestic bio industry held in Chosun Palace Seoul. Gangnam Hotel on the 15th. He said this.
According to Samsung BioLogics on the 16th, this event, held for the first time this year, was ready to discuss ways to develop the bio industry with industry officials, including domestic bio enterprises. About 60 people attended, including officials from 31 domestic bio enterprises and venture capitals, including clients Samsung Bio GI Innovation and LegoChem Bioscience.
CEO John Lim will secure new technologies and grow the domestic industry through the Life Science Fund worth about 170 billion won jointly with Samsung C&T and Samsung Bioepis and the Open Innovation Center to be built on 2nd Songdo Bio Campus. He announced that he will continue to invest for this purpose.
Next, a presentation was made on examples of strategic partnerships between Samsung Bio and domestic bio companies and the role of funds for the growth of the domestic bio industry and bio enterprises.
CEO Jonlim said, “I am glad that domestic bio companies can come together to discuss ways to develop K-Bio,” and added, “I hope this seminar will continue to be a venue exchange to discuss future development plans for the home. industry.”
Reporter Kim Hee-ri
#Jon #Lim #CEO #Samsung #Bio #Securing #growth #momentum #KBio #bold #investments
